Literature DB >> 7592026

Rifampicin inactivation by Bacillus species.

E R Dabbs1, K Yazawa, Y Tanaka, Y Mikami, M Miyaji, S J Andersen, N Morisaki, S Iwasaki, O Shida, H Takagi.   

Abstract

The ability of strains of Bacillus, Staphylococcus, Pseudomonas, and Escherichia coli to inactivate rifampicin was tested. Most Bacillus strains were found to inactivate rifampicin. Two modes of inactivation were identified; one was phosphorylation and the other involved decolorization. Presence or absence of either mechanism appeared unrelated to the phylogenetic relatedness of strains. None of the other organisms could inactivate this antibiotic.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7592026     DOI： 10.7164/antibiotics.48.815

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


  9 in total

1.  Bacillus subtilis tolerance of moderate concentrations of rifampin involves the sigma(B)-dependent general and multiple stress response.

Authors:  Julia Elisabeth Bandow; Heike Brötz; Michael Hecker
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

2.  Sequencing of the rpoB gene in Legionella pneumophila and characterization of mutations associated with rifampin resistance in the Legionellaceae.

Authors:  K Nielsen; P Hindersson; N Hoiby; J M Bangsborg
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

3.  Monooxygenase-like sequence of a Rhodococcus equi gene conferring increased resistance to rifampin by inactivating this antibiotic.

Authors:  S J Andersen; S Quan; B Gowan; E R Dabbs
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

4.  A rifamycin inactivating phosphotransferase family shared by environmental and pathogenic bacteria.

Authors:  Peter Spanogiannopoulos; Nicholas Waglechner; Kalinka Koteva; Gerard D Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

5.  Ribosylative inactivation of rifampin by Mycobacterium smegmatis is a principal contributor to its low susceptibility to this antibiotic.

Authors:  S Quan; H Venter; E R Dabbs
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

6.  Characterization of In53, a class 1 plasmid- and composite transposon-located integron of Escherichia coli which carries an unusual array of gene cassettes.

Authors:  T Naas; Y Mikami; T Imai; L Poirel; P Nordmann
Journal:  J Bacteriol       Date:  2001-01       Impact factor: 3.490

7.  Integron-mediated rifampin resistance in Pseudomonas aeruginosa.

Authors:  C Tribuddharat; M Fennewald
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

8.  Antibacterial and antivirulence effect of 6-N-hydroxylaminopurine in Listeria monocytogenes.

Authors:  Stefanie Sandra Krajewski; Isabelle Isoz; Jörgen Johansson
Journal:  Nucleic Acids Res       Date:  2017-02-28       Impact factor: 16.971

9.  Rifampin resistance and its fitness cost in Riemerella anatipestifer.

Authors:  Jiakai Sun; Dekang Zhu; Jinge Xu; Renyong Jia; Shun Chen; Mafeng Liu; Xinxin Zhao; Qiao Yang; Ying Wu; Shaqiu Zhang; Yunya Liu; Ling Zhang; Yanling Yu; Yu You; Mingshu Wang; Anchun Cheng
Journal:  BMC Microbiol       Date:  2019-05-23       Impact factor: 3.605
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.